GlassScriptPhysician profile
Crystal M Thayer
NPI 1437818523
$2,736.52
in general payments reported to CMS, 2019-2025
16 companies · $2,601 in 2025
The $2,601 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $136 · 2025: $2,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,559 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,558.62 |
| Education | $177.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $544.94 | 2025 | |
| Amgen INC. | $451.33 | 2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $409.60 | 2025 | Dupixent |
| Janssen Biotech, INC. | $299.87 | 2025 | Tremfya |
| Galderma Laboratories, L.P. | $236.55 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $188.31 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $170.88 | 2025 | |
| Genzyme Corporation | $135.94 | 2024 | |
| Organon LLC | $91.13 | 2025 | Vtama |
| Caris Mpi, INC. | $38.91 | 2025 | Mi Cancer Seek |
| Strata Skin Sciences, INC. | $36.70 | 2025 | Xtrac |
| Lnhc, INC | $30.19 | 2025 | Zelsuvmi |
| Sun Pharmaceutical Industries INC. | $29.31 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.72 | 2025 | Spevigo |
| Incyte Corporation | $26.40 | 2025 | Opzelura |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $19.74 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Thayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.